Patrick Crowley He played significant technical and management roles in the development to commercialisation of over 20 novel medicinal products and Product Line Extensions during a 38-year career in the pharmaceutical industry. Active ingredients in these medications included novel chemical entities, fermentation products, semi synthetics and two biopharmaceuticals. Products covered a full range of types (parenteral, oral, topical etc). He is the named Inventor of a number of Patents related to dosage form design and drug delivery.
Since retiring from GlaxoSmithKline in 2008 as a Vice President in Pharmaceutical Development he has operated as a Consultant for various multinational, mid-size and startup healthcare organizations in "trouble-shooting technical problems", product registrations (filings), dosage form development and patent litigation. He is a Visiting Professor at The School of Pharmacy, Kings College, University of London, teaching classes to Masters students on Biopharmaceuticals and Vaccines.
He is also currently working on a Team (based at King's College) developing an online teaching module for Biopharmaceuticals for Colleges throughout the European Union (PHAR-IN program), assembling the module for biopharmaceutical dosage form design, and manufacture. He is the author or co-author of several publications on various facets of pharmaceutical development.